New Commenary Addresses Impaired Driving due to Rx Drugs

Corinne Shea, IBH, Inc.

Robert L. DuPont, M.D., President of the Institute for Behavior and Health, Inc. (IBH) and Stephen K. Talpins, Chief Executive Officer of the National Partnership on Alcohol Misuse and Crime (NPAMC) discuss the problem of drug-impaired driving due to prescription drug use in the attached, new commentary.

Authors offer suggestions for how to reduce this ongoing public health and safety problem through a combination of education and law enforcement.

To access the report, click on the link below.

For more information, please contact:
Corinne Shea
(301) 231-9010

Related URLs:

IBH Commentary on Prescription Drugs